Company News

Share this article:

Sanofi-Aventis acquired Laboratorios Kendrick, a Mexican generic manufacturer. Sanofi hopes the purchase will extend its pharmaceutical portfolio in emerging markets. Laboratorios Kendric recorded sales of approximately $35 million in 2008.

 

Genzyme struck a deal with Bayer HealthCare to assume “primary responsibility” for the worldwide commercialization of Campath, a multiple sclerosis treatment. Genzyme also picked up Bayer's cancer drugs Fludara and Leukine, and will buy Bayer's Leukine manufacturing plant, near Seattle, for $75 - $100 million.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions